CoChat

Iron deficiency: an ominous sign in patients with systolic chronic heart failure

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

AIMS: Beyond erythropoiesis, iron is involved in numerous biological processes crucial for maintenance of homeostasis. Patients with chronic heart failure (CHF) are prone to develop iron deficiency (ID), and iron supplementation improves their functional status and quality of life. We sought to examine the relationship between ID and survival in patients with systolic CHF. METHODS AND RESULTS: In a prospective observational study, we evaluated 546 patients with stable systolic CHF [age: 55 +/- 11 (mean +/- standard deviation) years, males: 88%, left ventricular ejection fraction: 26 +/- 7%, New York Heart Association (NYHA) class (I/II/III/IV): 57/221/226/42]. Iron deficiency was defined as: ferritin <100 microg/L, or 100-300 microg/L with transferrin saturation <20%. The prevalence of ID was 37 +/- 4% [+/-95% confidence intervals (CI)] in the entire CHF population (32 +/- 4 vs. 57 +/- 10%-in subjects without vs. with anaemia defined as haemoglobin level <12 g/dL in women and <13 g/dL in men, P < 0.001). In a multiple logistic model, ID was more prevalent in women, those in the advanced NYHA class, with higher plasma N-terminal pro-type B natriuretic peptide and higher serum high-sensitivity C-reactive protein (all P < 0.05). At the end of follow-up (mean duration: 731 +/- 350 days), there were 153 (28%) deaths and 30 (6%) heart transplantations (HTX). In multivariable models, ID (but not anaemia) was related to an increased risk of death or HTX (adjusted hazard ratio 1.58, 95% CI 1.14-2.17, P < 0.01). CONCLUSION: In patients with systolic CHF, ID is common and constitutes a strong, independent predictor of unfavourable outcome. Iron supplementation may be considered as a therapeutic approach in these patients to improve prognosis.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehq158

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 3

  1. Usmanov, 2008, Journal of nephrology, 21, 236
  2. 1968, WHO TECH REP SER, 405, 1
  3. 2009, The Journal of nutritional biochemistry

Cited by

See all 652

Metadata

Authors
Jankowska, E. A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., Banasiak, W., Polonski, L., Filippatos, G., McMurray, J. J. V., Anker, S. D., & Ponikowski, P.
Affiliations
  • Wroclaw Medical University (PL)
  • Silesian Center for Heart Disease (PL)
  • Stiftung Charité (DE)
  • University General Hospital Attikon (GR)
  • University of Glasgow (GB)
  • Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Corresponding author
Jankowska, E. A.
Venue
European Heart Journal
Published
2010-06-21
Volume
31
Issue
15
Pages
1872-1880
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2002946832
Cited by
652
References
43
Citations by year
2026: 23 · 2025: 26 · 2024: 49 · 2023: 53 · 2022: 47 · 2021: 58 · 2020: 47 · 2019: 42 · 2018: 59 · 2017: 45 · 2016: 44 · 2015: 35 · 2014: 31 · 2013: 28 · 2012: 37
FWCI
18.42
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
iron deficiency, ferritin, transferrin saturation, mortality, heart transplantation, anemia, N-terminal proBNP, C-reactive protein, iron supplementation, prognosis
MeSH terms
Iron Deficiencies, Aged, C-Reactive Protein, Chronic Disease, Female, Ferritins, Humans, Male, Middle Aged, Peptide Fragments, Prognosis, Prospective Studies, Transferrin, Disease-Free Survival, Natriuretic Peptide, Brain, Kaplan-Meier Estimate, Heart Failure, Systolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Iron deficiency: an ominous sign in patients with systolic chronic heart failure. https://app.cochat.ai/papers/10.1093/eurheartj/ehq158
The paper
Jankowska, E. A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., Banasiak, W., Polonski, L., Filippatos, G., McMurray, J. J. V., Anker, S. D., & Ponikowski, P. (2010). Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European Heart Journal. https://doi.org/10.1093/eurheartj/ehq158

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.